Results
1 -
10 of
20
(Click
here to explore results)
- Theranostic inorganic–organic hybrid nanoparticles with a cocktail of chemotherapeutic and cytostatic drugs. Mikhail Khorenko, Juliana Pfeifer, Joanna Napp, Anna Meschkov, Frauke Alves, Ute Schepers, Claus Feldmann
, J. Mater. Chem. B
, 2023
, 11
, 3635
- Advances in technical strategies for monitoring the reduction of platinum(iv) complexes. Shu Chen, Qiyuan Zhou, Ka-Yan Ng, Zoufeng Xu, Weikang Xu, Guangyu Zhu
, Inorg. Chem. Front.
, 2024
- Novel anti-tubulin agents from plant and marine origins: insight from a molecular modeling and dynamics study. Umesh Yadava, Vivek Kumar Yadav, Ramesh Kumar Yadav
, RSC Adv.
, 2017
, 7
, 15917
- Antineoplastic drugs and their analysis: a state of the art review. Nicolas Guichard, Davy Guillarme, Pascal Bonnabry, Sandrine Fleury-Souverain
, Analyst
, 2017
, 142
, 2273
- Anticancer activity of a cis-dichloridoplatinum(ii) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathione. Subhendu Karmakar, Kallol Purkait, Saptarshi Chatterjee, Arindam Mukherjee
, Dalton Trans.
, 2016
, 45
, 3599
- Small hybrid heteroaromatics: resourceful biological tools in cancer research. Vikrant Abbot, Poonam Sharma, Saurabh Dhiman, Malleshappa N. Noolvi, Harun M. Patel, Varun Bhardwaj
, RSC Adv.
, 2017
, 7
, 28313
- Synthesis and characterization of thiocarbonato-linked platinum(iv) complexes. Marie-Christin Barth, Stefanie Lange, Norman Häfner, Nico Ueberschaar, Helmar Görls, Ingo B. Runnebaum, Wolfgang Weigand
, Dalton Trans.
, 2022
, 51
, 5567
- The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(iv) prodrugs. Shu Chen, Ka-Yan Ng, Qiyuan Zhou, Houzong Yao, Zhiqin Deng, Man-Kit Tse, Guangyu Zhu
, Dalton Trans.
, 2022
, 51
, 885
- Quantifying the hydrogen-bond propensity of drugs and its relationship with Lipinski's rule of five. Mambatta Haritha, Manikandan Sreerag, Cherumuttathu H. Suresh
, New J. Chem.
, 2024
, 48
, 4896
- Differential interactions of imatinib mesylate with the membrane skeletal protein spectrin and hemoglobin. Debashree Das, Ushasi Pramanik, Malay Patra, Mousumi Banerjee, Abhijit Chakrabarti
, RSC Adv.
, 2016
, 6
, 55203